Immunological follow-up of patients with neuromyelitis optica: Is there a good biomarker?

被引：7

作者：

Chanson, J-B ^{[1
,2
]}

de Seze, J. ^{[1
,2
]}

Eliaou, J-F ^{[3
]}

Vincent, T. ^{[3
]}

机构：

[1] Hop Univ Strasbourg, Dept Neurol, Strasbourg, France

[2] Univ Strasbourg, CNRS, LINC, Strasbourg, France

[3] CHU Montpellier, Hop St Eloi, Dept Immunol, F-34295 Montpellier 5, France

来源：

LUPUS | 2013年 / 22卷 / 03期

关键词：

Neuroimmunity; neuromyelitis optica; anti-aquaporin; 4; antibody; biomarker; follow-up; ANTI-AQUAPORIN-4; ANTIBODY; MULTIPLE-SCLEROSIS; T-CELLS; AQUAPORIN-4; DISEASE; MARKER; NMO; QUANTITATION; MULTICENTER; THERAPY;

D O I：

10.1177/0961203312467669

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A serial assessment of biomarkers related to disease activity could be clinically useful in some autoimmune diseases. Neuromyelitis optica (NMO) is a severe inflammatory disease of the optic nerves and spinal cord that can be associated with lupus erythematosus, Sjogren syndrome or myasthenia gravis. In this review, we discuss the existing data on the use of biomarkers of disease activity in NMO. A specific and pathogenic antibody (Ab) directed against aquaporin 4 (AQP4) was recently discovered in this disease. The relapses were frequently accompanied by a rise and immunosuppressive therapy by a decrease in serum anti-AQP4 Ab concentrations. However, this association is not strong enough to justify treatment changes based only on anti-AQP4 Ab level variations. This parameter might be helpful as a longitudinal biomarker but only if a threshold inducing a relapse and justifying a switch in therapy can be established. A link between disease severity and serum cytotoxicity against AQP4-expressing cells was proposed but has not yet been confirmed. Finally, the assessment of T cell immunity against AQP4 and specific cytokines could be future directions for research. Lupus (2013) 22, 229-232.

引用

页码：229 / 232

页数：4

共 30 条

[1] Neuromyelitis Optica: Pathogenicity of Patient Immunoglobulin In Vivo [J].

Bradl, Monika ;

Misu, Tatsuro ;

Takahashi, Toshiyuki ;

Watanabe, Mitsutoshi ;

Mader, Simone ;

Reindl, Markus ;

Adzemovic, Milena ;

Bauer, Jan ;

Berger, Thomas ;

Fujhara, Kazuo ;

Itoyama, Yasuto ;

Lassmann, Hans .

ANNALS OF NEUROLOGY, 2009, 66 (05) :630-643

[2]

Collongues Nicolas, 2011, Ther Adv Neurol Disord, V4, P111, DOI 10.1177/1756285611398939

[3] Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis [J].

de Seze, J ;

Lebrun, C ;

Stojkovic, T ;

Ferriby, D ;

Chatel, M ;

Vermersch, P .

MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (05) :521-525

[4] Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders [J].

Dujmovic, Irena ;

Mader, Simone ;

Schanda, Kathrin ;

Deisenhammer, Florian ;

Stojsavljevic, Nebojsa ;

Kostic, Jelena ;

Berger, Thomas ;

Drulovic, Jelena ;

Reindl, Markus .

JOURNAL OF NEUROIMMUNOLOGY, 2011, 234 (1-2) :124-130

[5] Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica [J].

Hinson, S. R. ;

Pittock, S. J. ;

Lucchinetti, C. F. ;

Roemer, S. F. ;

Fryer, J. P. ;

Kryzer, T. J. ;

Lennon, V. A. .

NEUROLOGY, 2007, 69 (24) :2221-2231

[6] Prediction of Neuromyelitis Optica Attack Severity by Quantitation of Complement-Mediated Injury to Aquaporin-4-Expressing Cells [J].

Hinson, Shannon R. ;

McKeon, Andrew ;

Fryer, James P. ;

Apiwattanakul, Metha ;

Lennon, Vanda A. ;

Pittock, Sean J. .

ARCHIVES OF NEUROLOGY, 2009, 66 (09) :1164-1167

[7] Antibody to aquaporin-4 in the long-term course of neuromyelitis optica [J].

Jarius, S. ;

Aboul-Enein, F. ;

Waters, P. ;

Kuenz, B. ;

Hauser, A. ;

Berger, T. ;

Lang, W. ;

Reindl, M. ;

Vincent, A. ;

Kristoferitsch, W. .

BRAIN, 2008, 131 :3072-3080

[8] Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients [J].

Jarius, Sven ;

Ruprecht, Klemens ;

Wildemann, Brigitte ;

Kuempfel, Tania ;

Ringelstein, Marius ;

Geis, Christian ;

Kleiter, Ingo ;

Kleinschnitz, Christoph ;

Berthele, Achim ;

Brettschneider, Johannes ;

Hellwig, Kerstin ;

Hemmer, Bernhard ;

Linker, Ralf A. ;

Lauda, Florian ;

Mayer, Christoph A. ;

Tumani, Hayrettin ;

Melms, Arthur ;

Trebst, Corinna ;

Stangel, Martin ;

Marziniak, Martin ;

Hoffmann, Frank ;

Schippling, Sven ;

Faiss, Juergen H. ;

Neuhaus, Oliver ;

Ettrich, Barbara ;

Zentner, Christian ;

Guthke, Kersten ;

Hofstadt-van Oy, Ulrich ;

Reuss, Reinhard ;

Pellkofer, Hannah ;

Ziemann, Ulf ;

Kern, Peter ;

Wandinger, Klaus P. ;

Bergh, Florian Then ;

Boettcher, Tobias ;

Langel, Stefan ;

Liebetrau, Martin ;

Rommer, Paulus S. ;

Niehaus, Sabine ;

Muench, Christoph ;

Winkelmann, Alexander ;

Zettl U, Uwe K. ;

Metz, Imke ;

Veauthier, Christian ;

Sieb, Joern P. ;

Wilke, Christian ;

Hartung, Hans P. ;

Aktas, Orhan ;

Paul, Friedemann .

JOURNAL OF NEUROINFLAMMATION, 2012, 9

[9] Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance [J].

Jarius, Sven ;

Franciotta, Diego ;

Paul, Friedemann ;

Ruprecht, Klemens ;

Bergamaschi, Roberto ;

Rommer, Paulus S. ;

Reuss, Reinhard ;

Probst, Christian ;

Kristoferitsch, Wolfgang ;

Wandinger, Klaus Peter ;

Wildemann, Brigitte .

JOURNAL OF NEUROINFLAMMATION, 2010, 7

[10] Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful? [J].

Kallenberg, C. G. M. ;

Stegeman, C. A. ;

Bootsma, H. ;

Biji, M. ;

Limburg, P. C. .

LUPUS, 2006, 15 (07) :397-402

← 1 2 3 →